Literature DB >> 32285417

Non-coding RNAs and Ischemic Cardiovascular Diseases.

Tarik Smani1,2, Isabel Mayoral-Gonzalez3,4, Isabel Galeano-Otero3, Isabel Gallardo-Castillo5, Juan A Rosado6, Antonio Ordoñez3,4,7, Abdelkrim Hmadcha8.   

Abstract

The Ischemic Heart Disease (IHD) is considered a clinical condition characterized by myocardial ischemia causing an imbalance between myocardial blood supply and demand, leading to morbidity and mortality across the worldwide. Prompt diagnostic and prognostic represents key factors for the treatment and reduction of the mortality rate. Therefore, one of the newest frontiers in cardiovascular research is related to non-coding RNAs (ncRNAs), which prompted a huge interest in exploring ncRNAs candidates for utilization as potential therapeutic targets for diagnostic and prognostic and/or biomarkers in IHD. However, there are undoubtedly many more functional ncRNAs yet to be discovered and characterized. Here we will discuss our current knowledge and we will provide insight on the roles and effects elicited by some ncRNAs related to IHD.

Entities:  

Keywords:  Cardioprotection; Ischemia and reperfusion; Non-coding RNAs; RNAs

Mesh:

Substances:

Year:  2020        PMID: 32285417     DOI: 10.1007/978-981-15-1671-9_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

Review 1.  Urocortin Role in Ischemia Cardioprotection and the Adverse Cardiac Remodeling.

Authors:  Eva M Calderón-Sánchez; Débora Falcón; Marta Martín-Bórnez; Antonio Ordoñez; Tarik Smani
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

2.  Differential Expression of miRNA-223 in Coronary In-Stent Restenosis.

Authors:  Shiva Ganjali; Seyed Hamid Aghaee-Bakhtiari; Željko Reiner; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2022-02-06       Impact factor: 4.241

3.  Cardiac protection induced by urocortin-2 enables the regulation of apoptosis and fibrosis after ischemia and reperfusion involving miR-29a modulation.

Authors:  Isabel Mayoral-González; Eva M Calderón-Sánchez; Isabel Galeano-Otero; Marta Martín-Bórnez; Encarnación Gutiérrez-Carretero; María Fernández-Velasco; Nieves Domenech; María Generosa Crespo-Leiro; Ana María Gómez; Antonio Ordóñez-Fernández; Abdelkrim Hmadcha; Tarik Smani
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-10       Impact factor: 8.886

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.